November 24, 2010
Research Findings Suggest new cause, possible treatment for multiple sclerosis
- /
Purdue University – Nov 23, 2010 WEST LAFAYETTE, Ind. – Researchers have found evidence that an environmental pollutant may…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
November 24, 2010
Of the MS Symposium, a Recent message from an MS Patient in Miami
- /
Stuart — You are to be commended for hosting the best MS program that Bunny & I have attended. All…
November 24, 2010
Novel compounds to promote remyelination in multiple sclerosis
- /
ABSTRACT: Multiple sclerosis (MS) is a chronic degenerative and debilitating disease of the central nervous system (CNS) characterized by inflammation…
November 23, 2010
An MS Patient’s Story: Multiple Sclerosis Not to Stop ‘Don’ from Skydiving for his 80th birthday…
- /
- /
As we approach the last quarter of our lives, none will escape problems with health: mental, physical or emotional. We…
November 23, 2010
Advocacy information from The Consortium of MS Centers
- /
Advocacy The Advocacy page provides resources and tools to ensure that patients’ needs and wishes are taken seriously and their…
November 23, 2010
Social Security Disability and Multiple Sclerosis: The Impact of the MS ‘Listing’
- /
- /
The path to social security disability benefits is almost invariably long and difficult. First, an individual’s disability must have progressed to…
November 23, 2010
Essential Elements Kit for the Newly Diagnosed
- /
In June 2009, the Consortium of Multiple Sclerosis Centers was proud to announce the launch of Essential Elements, a tool…
November 23, 2010
Information on new BETASERON (interferon beta – 1b) Injection Syringe
- /
As part of Bayer’s commitment to people with multiple sclerosis, we are pleased to introduce the new BETASERON® (interferon beta…
November 23, 2010
Sanofi-aventis Initiates Phase III Study with Teriflunomide plus Interferon Beta
- /
- /
Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple…
November 23, 2010
Merck KGaA: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MS
- /
- /
From the PharmaLive.com News Archive – Nov. 17, 2010 Darmstadt, Germany, November 17, 2010 – Merck KGaA announced today the completion of…
